期刊文献+

Fas/FasL在原发免疫性血小板减少症发病机制中的作用研究 被引量:6

Study on role of Fas/FasL in pathogenesis of primary immune thrombocytopenia
下载PDF
导出
摘要 目的探讨Fas及FasL系统在成年原发免疫性血小板减少症(ITP)发病机制中的作用。方法收集成年初诊ITP患者及健康成年人外周抗凝静脉血。采用流式细胞术检测ITP患者Th/Tc、Th1/Th2、Tc1/Tc2细胞Fas及FasL的表达率、血小板表面Fas及FasL的表达率。结果与健康对照组相比,ITP组Th、Th1、Th2、Tc、Tc1、Tc2细胞表面Fas及FasL的表达率均明显升高(P<0.05);同时ITP组血小板表面Fas的表达率明显升高(P<0.05),而血小板表面FasL的表达无明显变化(P>0.05)。结论 ITP患者T细胞亚群及血小板表面Fas及FasL表达的异常,可能与ITP发病机制密切相关。 Objective To explore the role of Fas and FasL system in the pathogenesis of adult primary immune thrombocytopenic purpura (ITP). Methods The peripheral anticoagulant venous blood samptes were collected from the patients with newly diagnosed ITP and healthy adults. The expression rates of Fas and FasL in Th/Tc, Th1/Th2, Tc1/Tc2 cells and theirexpression rates at platelet surface were detected by flow cytometry. Results The Fas and FasL expression rates on the surface of Th,Th1,Th2, Tc,Tc1 and Tc2 in the ITP group were increased compared with the healthy control group(P〈0.05). ,meanwhile the FasL expression on the platelet surface was significantly increased(P〈0.05), but the expression of FasL on the platelet surface had no obvious change(P〉0.05). Conclusion The Fas and FasL expression on T cell subsets and platelet surface in ITP patients is abnormal, which may be related with the pathogenesis of ITP.
出处 《重庆医学》 CAS 北大核心 2016年第20期2795-2797,2800,共4页 Chongqing medicine
基金 四川省卫生厅项目(110349) 泸州医学院附属医院青年人才基金[(2011)43号]
关键词 血小板减少 FAS/FASL系统 T细胞亚群 血小板 thrombocytopenia Fas/FasL system T cell subsets thrombocyte
  • 相关文献

参考文献4

二级参考文献35

  • 1Tormanen-Napankangas U, Soini Y, Kahlos K, et al. Expression of caspases-3, -6 and -8 and their relation to apoptosis in nonsmall cell lung carcinoma. Int J Cancer, 2001,93:192-198.
  • 2Hedlund-Treutiger I, Elinder G, Wigzell H, et al. T cell receptor V gene usage by CD4 + and CD8 + peripheral blood T lymphocytes in immune thrombocytopenic purpura. Acta Paediatr, 2004, 93 : 633-637.
  • 3Boatright KM, Salvesev GS. Mechanisms of caspase activation. Curr Opin Cell Biol, 2003, 15 : 725-731.
  • 4Liao WT, Chang KL, Yu CL, et al. Arsenic induces human keratinocyte apoptosis by the Fas/Fas ligand pathway, which correlates with alterations in nuclear factor-kappa B and activator protein-Ⅰ activity. J Invest Dermatol, 2004, 122: 125-129.
  • 5Yoshimura C, Nomura S, Nagahama M, et al. Plasma-soluble Fas ( APO-1, CD95 ) and soluble Fas ligand in immune thrombocytopenic purpura. Eur J Haematol, 2000, 64: 219-224.
  • 6Bohana-kashtan O, Ziporen L, Donin N, et al. Cell signals transduced by complement. Mol Immunol, 2004, 41:583-597.
  • 7Seery JP, Cattell V, Watt FM. Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanylaspartyl-( beta-o-methyl)-fluoromethylketone. J Immunol, 2001, 167:2452-2455.
  • 8Olsson B, Andersson PO, Jacobsson S, et al. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost,2005,93 : 139-144.
  • 9Ebata T, Mogi S, Hata Y, et al. Rapid induction of CD95 ligand and CD4 + T cell-mediated apoptosis by CD137 (4-1BB) costimulation. Eur J Immunol, 2001, 31:1410-1416.
  • 10[1]Clarke P G H.Developmental cell death: morphological diversity and multiple mechanism. Anat Embryol, 1990,181(3):195-201.

共引文献49

同被引文献134

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部